- Home
- ARVN vs BV Comparison
ARVN vs BV Comparison
Compare ARVN & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- BV
- Stock Information
- Founded
- ARVN 2015
- BV 1939
- Country
- ARVN United States
- BV United States
- Employees
- ARVN N/A
- BV N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- BV Business Services
- Sector
- ARVN Health Care
- BV Consumer Discretionary
- Exchange
- ARVN Nasdaq
- BV Nasdaq
- Market Cap
- ARVN 1.7B
- BV 1.5B
- IPO Year
- ARVN 2018
- BV 2018
- Fundamental
- Price
- ARVN $25.11
- BV $16.64
- Analyst Decision
- ARVN Strong Buy
- BV Buy
- Analyst Count
- ARVN 13
- BV 7
- Target Price
- ARVN $61.08
- BV $16.65
- AVG Volume (30 Days)
- ARVN 718.1K
- BV 470.4K
- Earning Date
- ARVN 10-30-2024
- BV 11-13-2024
- Dividend Yield
- ARVN N/A
- BV N/A
- EPS Growth
- ARVN N/A
- BV N/A
- EPS
- ARVN N/A
- BV 0.20
- Revenue
- ARVN $161,100,000.00
- BV $2,767,100,000.00
- Revenue This Year
- ARVN $237.44
- BV $4.33
- Revenue Next Year
- ARVN N/A
- BV $3.01
- P/E Ratio
- ARVN N/A
- BV $78.70
- Revenue Growth
- ARVN 1.07
- BV N/A
- 52 Week Low
- ARVN $21.17
- BV $7.29
- 52 Week High
- ARVN $53.08
- BV $18.89
- Technical
- Relative Strength Index (RSI)
- ARVN 48.81
- BV 50.00
- Support Level
- ARVN $21.17
- BV $15.42
- Resistance Level
- ARVN $28.70
- BV $18.89
- Average True Range (ATR)
- ARVN 1.72
- BV 0.71
- MACD
- ARVN -0.41
- BV -0.23
- Stochastic Oscillator
- ARVN 51.44
- BV 42.16
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.